Michael F. MacLean

Insider Reports History

Location
San Diego, CA
Signature
/s/ John B. Moriarty, Jr., J.D., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael F. MacLean:

Company Role Class Num Shares Value Price $ Report Date Ownership
Avidity Biosciences, Inc. Chief Financial Officer Common Stock 63,832 $4,610,585 $72.23 07 Jan 2026 Direct
Verve Therapeutics, Inc. Director Stock Option (right to buy) 0 25 Jul 2025 Direct

Insider Reports Filed by Michael F. MacLean

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RNA Avidity Biosciences, Inc. 07 Jan 2026 1 -$142,582 4 Chief Financial Officer 09 Jan 2026, 17:12
RNA Avidity Biosciences, Inc. 06 Aug 2025 1 -$1,320,844 4 Chief Financial Officer 15 Aug 2025, 16:09
VERV Verve Therapeutics, Inc. 25 Jul 2025 2 $0 4 Director 28 Jul 2025, 17:15
VERV Verve Therapeutics, Inc. 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 17:00
RNA Avidity Biosciences, Inc. 20 Mar 2025 1 -$246,425 4 Chief Financial Officer 21 Mar 2025, 18:38
RNA Avidity Biosciences, Inc. 21 Jan 2025 2 -$93,985 4 Chief Financial Officer 23 Jan 2025, 20:15
RNA Avidity Biosciences, Inc. 06 Jan 2025 2 $0 4 Chief Financial Officer 08 Jan 2025, 20:26
RNA Avidity Biosciences, Inc. 18 Dec 2024 1 -$364,192 4 Chief Financial Officer 19 Dec 2024, 18:16
RNA Avidity Biosciences, Inc. 06 Nov 2024 7 -$4,177,915 4 Chief Financial Officer 08 Nov 2024, 16:50
RNA Avidity Biosciences, Inc. 19 Sep 2024 3 -$506,440 4 Chief Financial Officer 23 Sep 2024, 20:59
VERV Verve Therapeutics, Inc. 26 Jun 2024 1 $0 4 Director 28 Jun 2024, 07:45
RNA Avidity Biosciences, Inc. 17 Jun 2024 3 -$439,345 4 Chief Financial Officer 20 Jun 2024, 18:48
RNA Avidity Biosciences, Inc. 12 Jun 2024 3 -$2,803,701 4 Chief Financial Officer 14 Jun 2024, 19:07
RNA Avidity Biosciences, Inc. 14 May 2024 3 -$1,459,545 4 Chief Financial Officer 16 May 2024, 18:25
RNA Avidity Biosciences, Inc. 13 Mar 2024 3 -$627,960 4 Chief Financial Officer 15 Mar 2024, 16:12
RNA Avidity Biosciences, Inc. 20 Jan 2024 3 -$16,370 4 Chief Financial Officer 23 Jan 2024, 15:11
RNA Avidity Biosciences, Inc. 11 Sep 2023 1 $0 4 Chief Financial Officer 12 Sep 2023, 20:33
VERV Verve Therapeutics, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 17:00
VERV Verve Therapeutics, Inc. 14 Feb 2023 1 $0 4 Director 16 Feb 2023, 16:00
RNA Avidity Biosciences, Inc. 20 Jan 2023 2 $0 4 Chief Financial Officer 24 Jan 2023, 20:06
VERV Verve Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 17:00
RNA Avidity Biosciences, Inc. 21 Jan 2022 1 $0 4 Chief Financial Officer 15 Mar 2022, 21:18
VERV Verve Therapeutics, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 18:21
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 Director 16 Jun 2021, 19:40